Otsuka Pharmaceutical won’t charge South Africa for using its new tuberculosis (TB) drug, delanimid, oneof the first new TB medicines to be developed in 50 years, in...Health Policy
The health risk posed by state hospitals discharging patients with totally drug resistant TB was a 'ticking time bomb', says Professor Keertan Dheeda of the University...
November 2nd, 2016A three-drug regimen trialled on South African tuberculosis patients, half of whom were also HIV positive, has delivered results described as a 'phenomenal...
